DE60233420D1 - Fumagillolderivate und verfahren zu deren herstellung - Google Patents

Fumagillolderivate und verfahren zu deren herstellung

Info

Publication number
DE60233420D1
DE60233420D1 DE60233420T DE60233420T DE60233420D1 DE 60233420 D1 DE60233420 D1 DE 60233420D1 DE 60233420 T DE60233420 T DE 60233420T DE 60233420 T DE60233420 T DE 60233420T DE 60233420 D1 DE60233420 D1 DE 60233420D1
Authority
DE
Germany
Prior art keywords
angiogenesis
preparation
fumagillol derivatives
fumagillol
psoriasis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60233420T
Other languages
English (en)
Inventor
Cheol-Kyu Han
Jeong-Hyeok Yoon
Seung-Moak Kim
Nam-Doo Kim
Byung-Ha Chang
Jee-Young Lee
Tae-Bo Sim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Equispharm Co Ltd
Original Assignee
Equispharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR10-2001-0060017A external-priority patent/KR100455900B1/ko
Priority claimed from KR10-2002-0029915A external-priority patent/KR100483836B1/ko
Application filed by Equispharm Co Ltd filed Critical Equispharm Co Ltd
Application granted granted Critical
Publication of DE60233420D1 publication Critical patent/DE60233420D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
DE60233420T 2001-09-27 2002-06-11 Fumagillolderivate und verfahren zu deren herstellung Expired - Lifetime DE60233420D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2001-0060017A KR100455900B1 (ko) 2001-09-27 2001-09-27 새로운 푸마질롤 유도체 및 그의 제조방법
KR10-2002-0029915A KR100483836B1 (ko) 2002-05-29 2002-05-29 푸마질롤 유도체 및 그의 제조방법
PCT/KR2002/001102 WO2003027104A1 (en) 2001-09-27 2002-06-11 Fumagillol derivatives and preparing method thereof

Publications (1)

Publication Number Publication Date
DE60233420D1 true DE60233420D1 (de) 2009-10-01

Family

ID=26639368

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60233420T Expired - Lifetime DE60233420D1 (de) 2001-09-27 2002-06-11 Fumagillolderivate und verfahren zu deren herstellung

Country Status (5)

Country Link
US (3) US7087768B2 (de)
EP (1) EP1436286B1 (de)
AT (1) ATE440094T1 (de)
DE (1) DE60233420D1 (de)
WO (1) WO2003027104A1 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003027104A1 (en) * 2001-09-27 2003-04-03 Idrtech Inc. Fumagillol derivatives and preparing method thereof
KR100552043B1 (ko) * 2004-02-28 2006-02-20 주식회사종근당 푸마질롤 유도체를 포함하는 비만치료용 조성물
WO2006080591A1 (en) * 2005-01-26 2006-08-03 Chong Kun Dang Pharmaceutical Corp. Fumagillol derivatives or method for preparation of fumagillol derivatives, and pharmaceutical compositions comprising the same
WO2009003110A2 (en) 2007-06-26 2008-12-31 Children's Medical Center Corporation Metap-2 inhibitor polymersomes for therapeutic administration
AU2008331516B2 (en) * 2007-11-28 2014-01-09 Mersana Therapeutics, Inc. Biocompatible biodegradable fumagillin analog conjugates
US8865746B2 (en) 2008-07-18 2014-10-21 Zafgen, Inc. Methods of treating an overweight or obese subject
US8642650B2 (en) 2008-12-04 2014-02-04 Zafgen, Inc. Methods of treating an overweight or obese subject
WO2010065877A2 (en) 2008-12-04 2010-06-10 Zafgen Corporation Methods of treating an overweight or obese subject
MX337575B (es) 2009-10-09 2016-03-10 Zafgen Corp Compuestos de sulfona y métodos para lafabricación y uso de éstos.
WO2011085198A1 (en) 2010-01-08 2011-07-14 Zafgen Corporation Metap-2 inhibitor for use in treating benign prostatic hypertrophy (bph)
BR112012016793A2 (pt) 2010-01-08 2018-07-31 Zafgen Corp compostos tipo fumagilol e métodos de fazer e usar os mesmos
WO2011127304A2 (en) 2010-04-07 2011-10-13 Zafgen Corporation Methods of treating an overweight subject
CN107158398B (zh) 2010-05-25 2022-02-18 辛德弗雷克斯公司 聚合物缀合的MetAP2抑制剂及其应用的治疗方法
US9895449B2 (en) 2010-05-25 2018-02-20 Syndevrx, Inc. Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof
BR112013001613A2 (pt) 2010-07-22 2016-05-24 Zafgen Inc compostos tricíclicos e métodos para fazer e usar os mesmos.
EP2638023B1 (de) 2010-11-09 2016-09-07 Zafgen, Inc. Crystalline feststoffe von einem metap-2-hemmer, verfahren zu deren herstellung und verwendung
CN103379905A (zh) 2010-11-29 2013-10-30 扎夫根股份有限公司 使用非每天施用的6-0-(4-二甲基氨基乙氧基)肉桂酰烟曲霉醇治疗肥胖症
US9321740B2 (en) 2011-01-26 2016-04-26 Zafgen, Inc. Tetrazole compounds and methods of making and using same
KR101875988B1 (ko) 2011-03-08 2018-07-06 자프겐 인크. 옥사스피로[2.5]옥탄 유도체 및 유사체
FR2973376B1 (fr) * 2011-03-28 2013-05-10 Atlanthera Derives utiles dans le traitement ou la prevention de tumeurs osseuses
EA025526B1 (ru) 2011-05-06 2017-01-30 Зафджен Инк. Частично насыщенные трициклические соединения и способы их получения и применения
CA2835195A1 (en) 2011-05-06 2012-11-15 Zafgen, Inc. Tricyclic sulfonamide compounds and methods of making and using same
JP6035327B2 (ja) 2011-05-06 2016-11-30 ザフゲン，インコーポレイテッド 三環式ピラゾールスルホンアミド化合物ならびにその製造および使用方法
EP2763671A2 (de) 2011-10-03 2014-08-13 Zafgen, Inc. Verfahren zur behandlung von altersbedingten erkrankungen
JP2015509102A (ja) 2012-01-18 2015-03-26 ザフゲン，インコーポレイテッド 三環式スルホン化合物並びにその作製および使用方法
KR20140112565A (ko) 2012-01-18 2014-09-23 자프겐 인크. 삼환식 설폰아마이드 화합물 그리고 그의 제조방법 및 그를 이용하는 방법
BR112014027808A2 (pt) 2012-05-07 2017-06-27 Zafgen Inc sal polimórfico do sal de oxalato de 6-o-(4-dimetilaminoetoxi) cinaroil fumagilol e métodos de produção e utilização do mesmo
MX2014013599A (es) 2012-05-08 2015-05-11 Zafgen Inc Tratamiento de la obesidad hipotalamica con inhibidores de metap2.
CN104364251B (zh) 2012-05-09 2017-02-22 扎夫根股份有限公司 烟曲霉醇型化合物及其制备和使用方法
EP2916833A1 (de) 2012-11-05 2015-09-16 Zafgen, Inc. Verfahren zur behandlung von lebererkrankungen
BR112015010223A2 (pt) 2012-11-05 2017-07-11 Zafgen Inc compostos tricíclicos para o uso no tratamento e/ou controle de obesidade
KR20150079952A (ko) 2012-11-05 2015-07-08 자프겐 인크. 트리시클릭 화합물 및 그의 제조 및 사용 방법
WO2014152861A2 (en) 2013-03-14 2014-09-25 Zafgen, Inc. Methods of treating renal disease and other disorders
MX371095B (es) 2013-04-10 2020-01-16 Syndevrx Inc Inhibidores de metionina aminopeptidasa-2 y metodos de tratamiento de la obesidad.
TW201636342A (zh) 2014-12-19 2016-10-16 武田藥品工業有限公司 煙黴醇衍生物
AR105671A1 (es) 2015-08-11 2017-10-25 Zafgen Inc Compuestos heterocíclicos de fumagillol y sus métodos de elaboración y uso
CN106432255A (zh) 2015-08-11 2017-02-22 扎夫根公司 烟曲霉素醇螺环化合物和制备和使用其的方法
ES2893749T3 (es) 2015-12-10 2022-02-10 Syndevrx Inc Derivados de fumagilol y polimorfos de los mismos
CA3008960A1 (en) 2016-01-11 2017-07-20 Syndevrx, Inc. Treatment for tumors driven by metabolic dysfunction
US11612577B2 (en) 2018-10-26 2023-03-28 Syndevrx, Inc. Biomarkers of METAP2 inhibitors and applications thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164410A (en) * 1988-01-09 1992-11-17 Takeda Chemical Industries, Ltd. Fumagillol derivatives and pharmaceutical compositions thereof
DE68927904T2 (de) * 1988-09-01 1997-09-04 Takeda Chemical Industries Ltd Fumagillol-Derivate
US5166172A (en) * 1988-09-01 1992-11-24 Takeda Chemical Industries, Ltd. Fumagillol derivatives and pharmaceutical compositions thereof
ES2053890T3 (es) * 1988-09-01 1994-08-01 Takeda Chemical Industries Ltd Agente inhibidor de la angiogenesis.
US5180738A (en) * 1988-09-01 1993-01-19 Takeda Chemical Industries Fumagillol derivatives and pharmaceutical compositions thereof
EP0387650B1 (de) 1989-03-06 1993-03-31 Takeda Chemical Industries, Ltd. 6-Epifumagillole, ihre Herstellung und ihre Verwendung
US5290807A (en) * 1989-08-10 1994-03-01 Children's Medical Center Corporation Method for regressing angiogenesis using o-substituted fumagillol derivatives
EP0415294A3 (en) * 1989-08-31 1991-06-12 Takeda Chemical Industries, Ltd. Cyclohexanol derivatives, production and use thereof
TW282399B (de) * 1990-05-25 1996-08-01 Takeda Pharm Industry Co Ltd
EP0799616A1 (de) * 1996-04-01 1997-10-08 Takeda Chemical Industries, Ltd. Orale Zubereitung enthaltend ein Fumagillolderivat
DE19653036A1 (de) * 1996-12-19 1998-06-25 Merck Patent Gmbh Cyclopeptidderivate
US6207704B1 (en) 1997-06-09 2001-03-27 Massachusetts Institute Of Technology Type 2 methionine aminopeptidase [MetAP2] inhibitors and uses thereof
KR100357541B1 (ko) * 1998-05-15 2002-10-18 주식회사종근당 5-데메톡시 푸마질롤 유도체 및 그 제조방법
EP1202733B1 (de) * 1999-08-12 2005-10-05 Pharmacia Italia S.p.A. 3(5)-amino-pyrazolderivate, deren herstellungsverfahren und verwendung als krebshemmende mittel
US6114365A (en) * 1999-08-12 2000-09-05 Pharmacia & Upjohn S.P.A. Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents
US6458810B1 (en) * 2000-11-14 2002-10-01 George Muller Pharmaceutically active isoindoline derivatives
WO2003027104A1 (en) * 2001-09-27 2003-04-03 Idrtech Inc. Fumagillol derivatives and preparing method thereof
WO2003037330A1 (en) * 2001-11-02 2003-05-08 Pfizer Products Inc. Sulfonyl-and sulfonylheteroaryl-pyrazoles with a hydrazinyl or nitrogen oxide substituent at the 5-position for use as cyclooxygenase inhibitors

Also Published As

Publication number Publication date
EP1436286B1 (de) 2009-08-19
WO2003027104A1 (en) 2003-04-03
EP1436286A1 (de) 2004-07-14
US7087768B2 (en) 2006-08-08
US20060276512A1 (en) 2006-12-07
ATE440094T1 (de) 2009-09-15
US20070149613A1 (en) 2007-06-28
US20040242681A1 (en) 2004-12-02
EP1436286A4 (de) 2004-12-15

Similar Documents

Publication Publication Date Title
DE60233420D1 (de) Fumagillolderivate und verfahren zu deren herstellung
NL300933I2 (nl) Letermovir
BR0312957A (pt) Composto ou um sal farmaceuticamente aceitável deste, uso do mesmo, composição farmacêutica, e, método para produzir um efeito inibidor de 11betahsd1 em um animal de sangue quente, tal como o homem, em necessidade de tal tratamento
GT200100183A (es) Derivados de quinolina y quinazolina.
BRPI0413452A (pt) composto, composição farmacêutica, kit, artigo de fabricação, e, métodos de inibir dpp-iv, terapêutico e de tratar um estado de doença, cáncer, distúrbios autoimunes, uma condição einfecção por hiv
EA200400368A1 (ru) Новые дигидроптеридиноны, способы их получения и их применение в качестве лекарственных средств
WO2004078144A3 (en) Diphenylethylene compounds and uses thereof
HRP20080664A2 (en) Substituted pyridine herbicides
GT200000103A (es) Trifluorbutenos nematocidas.
ATE556074T1 (de) Neue imidazoä1,5-aüpyridinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die diese enthalten
SE0301888D0 (sv) New use VII
SE0301882D0 (sv) New use I
ATE441630T1 (de) Substituierte cyclopenten-verbindungen
UA85559C2 (en) Aminobenzophenone compounds
CR9182A (es) Derivado de quinolina, su uso, preparacion y medicamento que lo contiene
WO2006100082A3 (de) Substituierte oxindol-derivate, diese enthaltende arzneimittel und deren verwendung
RS20050974A (en) Heterocyclically substituted pentanol derivatives,method for the production thereof,and use thereof as anti- inflammatory agents
SE0302324D0 (sv) Novel compounds
ECSP055844A (es) Nuevos compuestos triciclicos
HRP20050439B1 (en) New use of dextran sulfate
BR122018009866B8 (pt) métodos para preparar compostos de éter aminocicloexílico e compostos intermediários
SE0302323D0 (sv) Novel compounds
CY1112191T1 (el) Παραγωγο πυραζολοπυριμιδινης
UY26133A1 (es) Derivado sustituido de pirazol.
BR0312863A (pt) Derivados de aldeìdo de polietileno glicol

Legal Events

Date Code Title Description
8364 No opposition during term of opposition